Research Article

Docking Studies, Synthesis, Characterization and Evaluation of Their Antioxidant and Cytotoxic Activities of Some Novel Isoxazole-Substituted 9-Anilinoacridine Derivatives

Table 1

Antioxidant activity of synthesized compounds 4a–j and 5a–j by DPPH method, reducing power assay and total antioxidant capacity method.

S. NoCpd. CodeIC50 values for DPPH method (μg/mL)IC50 values for reducing power assay (μg/mL)IC50 values for TAC (μg/mL)

(1)4a>1000>500>500
(2)4b>1000>500>500
(3)4c>1000>500>500
(4)4d>1000>500>500
(5)4e>1000>500>500
(6)4f>1000>500>500
(7)4g>1000>500>500
(8)4h>1000>500>500
(9)4i>1000>500>500
(10)4j>1000>500>500
(11)5a 1 8 . 3 0 ± 0 . 4 5 8 3 3 4 . 1 7 ± 0 . 5 7 8 3 8 9 . 6 0 ± 0 . 7 7 6 7
(12)5b 5 0 . 2 3 ± 1 . 0 4 8 6 8 . 2 7 ± 0 . 5 6 0 8 1 2 2 . 0 ± 1 . 0 4 4
(13)5c 1 7 . 5 3 ± 0 . 0 8 8 2 2 . 1 3 ± 0 . 5 0 4 4 9 2 . 8 0 ± 0 . 9 0 7 4
(14)5d 1 4 . 2 0 ± 0 . 1 5 2 8 2 6 . 4 3 ± 0 . 5 6 9 6 8 1 . 8 3 ± 0 . 2 4 0 4
(15)5e 3 3 . 2 0 ± 1 . 3 2 3 4 3 . 3 7 ± 0 . 5 9 2 5 1 1 1 . 8 ± 0 . 8 8 1 9
(16)5f 1 2 . 6 7 ± 0 . 1 2 0 2 2 9 . 5 0 ± 0 . 8 7 1 8 9 1 . 4 3 ± 0 . 2 4 0 4
(17)5g 2 7 . 0 0 ± 0 . 8 6 6 0 4 7 . 0 3 ± 1 . 0 3 5 1 3 2 . 3 ± 0 . 8 0 9 0
(18)5h 2 8 . 2 0 ± 0 . 3 4 6 4 3 7 . 3 0 ± 0 . 4 6 1 9 7 5 . 4 3 ± 0 . 2 4 0 4
(19)5i 1 3 . 6 3 ± 0 . 1 7 6 4 1 9 . 2 3 ± 0 . 4 6 6 7 9 5 . 4 3 ± 0 . 2 4 0 4
(20)5j 1 6 . 3 0 ± 0 . 5 5 6 8 2 0 . 5 3 ± 1 . 0 0 4 6 5 . 9 7 ± 0 . 5 2 0 7
(21)Standard ascorbic acid 1 8 . 6 0 ± 1 . 0 3 9 2 4 . 7 7 ± 0 . 2 4 0 4 8 6 . 1 7 ± 0 . 5 7 8 3